Tolmar recalls
FDA enforcement reports naming Tolmar, Inc. as the recalling firm.
- Recall reports
- 3
- Class I (serious)
- 0
- Most recent report
- Oct 4, 2023
- Oct 4, 2023Eligard (leuprolide acetate) for injectable suspension, 7Drug · Tolmar, Inc.Superpotent Drug - Higher than expected levels of leuprolide acetate in the constituted product.Class III
- Aug 10, 2022Naftifine Hydrochloride Gel, USP 1%, packaged in cartons with: a) Net WtDrug · Tolmar, Inc.Failed Impurities/ degradation specifications: Out-of-Specification test results obtained for Unspecified Impurity Relative Retention TimeClass II
- Dec 22, 2021Clindamycin and Benzoyl Peroxide Gel, 1%/5% 25 g jars, Rx only, Mfg by TOLMAR IncDrug · TOLMAR, Inc.Superpotent DrugClass II